nodes	percent_of_prediction	percent_of_DWPC	metapath
Maraviroc—CCR5—blood plasma—schizophrenia	0.119	0.343	CbGeAlD
Maraviroc—CCR5—blood—schizophrenia	0.0435	0.126	CbGeAlD
Maraviroc—CCR5—endocrine gland—schizophrenia	0.0377	0.109	CbGeAlD
Maraviroc—CCR5—nervous system—schizophrenia	0.0353	0.102	CbGeAlD
Maraviroc—CCR5—central nervous system—schizophrenia	0.034	0.0982	CbGeAlD
Maraviroc—CCR5—brain—schizophrenia	0.027	0.0779	CbGeAlD
Maraviroc—CYP3A4—urine—schizophrenia	0.0229	0.0662	CbGeAlD
Maraviroc—CYP3A4—blood plasma—schizophrenia	0.012	0.0346	CbGeAlD
Maraviroc—CYP3A4—blood—schizophrenia	0.00438	0.0127	CbGeAlD
Maraviroc—CYP3A4—endocrine gland—schizophrenia	0.0038	0.011	CbGeAlD
Maraviroc—CYP3A4—nervous system—schizophrenia	0.00356	0.0103	CbGeAlD
Maraviroc—CCR5—GPCR ligand binding—GRM5—schizophrenia	0.00354	0.00541	CbGpPWpGaD
Maraviroc—CCR5—GPCRs, Class A Rhodopsin-like—CNR1—schizophrenia	0.00347	0.0053	CbGpPWpGaD
Maraviroc—CCR5—Class A/1 (Rhodopsin-like receptors)—HTR1A—schizophrenia	0.00343	0.00524	CbGpPWpGaD
Maraviroc—CYP3A4—central nervous system—schizophrenia	0.00343	0.0099	CbGeAlD
Maraviroc—CCR5—GPCRs, Class A Rhodopsin-like—HTR7—schizophrenia	0.00338	0.00517	CbGpPWpGaD
Maraviroc—CCR5—GPCRs, Class A Rhodopsin-like—DRD2—schizophrenia	0.00338	0.00517	CbGpPWpGaD
Maraviroc—CCR5—Class A/1 (Rhodopsin-like receptors)—NPS—schizophrenia	0.00337	0.00516	CbGpPWpGaD
Maraviroc—CCR5—Signaling by GPCR—DGKI—schizophrenia	0.00331	0.00506	CbGpPWpGaD
Maraviroc—CYP3A4—Codeine and Morphine Metabolism—ABCB1—schizophrenia	0.00331	0.00506	CbGpPWpGaD
Maraviroc—CCR5—Class A/1 (Rhodopsin-like receptors)—DRD1—schizophrenia	0.00331	0.00506	CbGpPWpGaD
Maraviroc—CCR5—Class A/1 (Rhodopsin-like receptors)—HTR2C—schizophrenia	0.00331	0.00506	CbGpPWpGaD
Maraviroc—CCR5—TCR Signaling Pathway—IL1B—schizophrenia	0.00326	0.00499	CbGpPWpGaD
Maraviroc—CCR5—GPCR ligand binding—CCK—schizophrenia	0.00323	0.00494	CbGpPWpGaD
Maraviroc—CCR5—Class A/1 (Rhodopsin-like receptors)—DRD3—schizophrenia	0.0032	0.0049	CbGpPWpGaD
Maraviroc—CCR5—Class A/1 (Rhodopsin-like receptors)—DRD4—schizophrenia	0.00311	0.00476	CbGpPWpGaD
Maraviroc—CCR5—GPCR ligand binding—CCKAR—schizophrenia	0.0031	0.00474	CbGpPWpGaD
Maraviroc—CCR5—Signaling by GPCR—PPP1R1B—schizophrenia	0.00303	0.00463	CbGpPWpGaD
Maraviroc—CCR5—GPCR ligand binding—ADORA2A—schizophrenia	0.00301	0.0046	CbGpPWpGaD
Maraviroc—CCR5—Class A/1 (Rhodopsin-like receptors)—CNR1—schizophrenia	0.00297	0.00454	CbGpPWpGaD
Maraviroc—CCR5—Disease—NDST3—schizophrenia	0.00295	0.00451	CbGpPWpGaD
Maraviroc—CCR5—GPCR downstream signaling—TAAR6—schizophrenia	0.00292	0.00446	CbGpPWpGaD
Maraviroc—CCR5—GPCR downstream signaling—GRM2—schizophrenia	0.00292	0.00446	CbGpPWpGaD
Maraviroc—CCR5—Class A/1 (Rhodopsin-like receptors)—HTR7—schizophrenia	0.0029	0.00443	CbGpPWpGaD
Maraviroc—CCR5—Class A/1 (Rhodopsin-like receptors)—DRD2—schizophrenia	0.0029	0.00443	CbGpPWpGaD
Maraviroc—CCR5—Signaling by GPCR—FZD3—schizophrenia	0.00282	0.00431	CbGpPWpGaD
Maraviroc—CCR5—GPCR ligand binding—NPY—schizophrenia	0.00281	0.0043	CbGpPWpGaD
Maraviroc—CCR5—GPCR ligand binding—OXT—schizophrenia	0.00271	0.00414	CbGpPWpGaD
Maraviroc—CCR5—GPCR ligand binding—HTR1B—schizophrenia	0.00271	0.00414	CbGpPWpGaD
Maraviroc—CCR5—GPCR downstream signaling—NGEF—schizophrenia	0.0027	0.00412	CbGpPWpGaD
Maraviroc—CYP3A4—Fatty Acid Omega Oxidation—CYP2D6—schizophrenia	0.00266	0.00407	CbGpPWpGaD
Maraviroc—CCR5—Signaling by GPCR—PPP3CC—schizophrenia	0.00265	0.00405	CbGpPWpGaD
Maraviroc—CCR5—Signaling by GPCR—GRM2—schizophrenia	0.00265	0.00405	CbGpPWpGaD
Maraviroc—CCR5—Signaling by GPCR—TAAR6—schizophrenia	0.00265	0.00405	CbGpPWpGaD
Maraviroc—CCR5—GPCR downstream signaling—NTS—schizophrenia	0.00264	0.00403	CbGpPWpGaD
Maraviroc—CCR5—GPCR ligand binding—HTR1A—schizophrenia	0.00261	0.00399	CbGpPWpGaD
Maraviroc—CCR5—GPCR ligand binding—NPS—schizophrenia	0.00257	0.00393	CbGpPWpGaD
Maraviroc—CCR5—Disease—IPO5—schizophrenia	0.00255	0.00391	CbGpPWpGaD
Maraviroc—CCR5—GPCR ligand binding—HTR2C—schizophrenia	0.00252	0.00385	CbGpPWpGaD
Maraviroc—CCR5—GPCR ligand binding—DRD1—schizophrenia	0.00252	0.00385	CbGpPWpGaD
Maraviroc—CCR5—GPCR downstream signaling—GRM3—schizophrenia	0.00248	0.00379	CbGpPWpGaD
Maraviroc—CCR5—GPCR downstream signaling—RGS4—schizophrenia	0.00248	0.00379	CbGpPWpGaD
Maraviroc—CCR5—Signaling by GPCR—NGEF—schizophrenia	0.00245	0.00375	CbGpPWpGaD
Maraviroc—CCR5—GPCR ligand binding—DRD3—schizophrenia	0.00244	0.00373	CbGpPWpGaD
Maraviroc—CCR5—GPCR downstream signaling—HTR6—schizophrenia	0.00243	0.00372	CbGpPWpGaD
Maraviroc—CYP3A4—Fatty Acid Omega Oxidation—CYP1A2—schizophrenia	0.00241	0.00368	CbGpPWpGaD
Maraviroc—CCR5—Signaling by GPCR—NTS—schizophrenia	0.00239	0.00366	CbGpPWpGaD
Maraviroc—CCR5—GPCRs, Class A Rhodopsin-like—HTR2A—schizophrenia	0.00237	0.00362	CbGpPWpGaD
Maraviroc—CCR5—GPCR ligand binding—DRD4—schizophrenia	0.00237	0.00362	CbGpPWpGaD
Maraviroc—CCR5—GPCR ligand binding—CNR1—schizophrenia	0.00226	0.00346	CbGpPWpGaD
Maraviroc—CCR5—Signaling by GPCR—GRM3—schizophrenia	0.00225	0.00344	CbGpPWpGaD
Maraviroc—CCR5—Signaling by GPCR—RGS4—schizophrenia	0.00225	0.00344	CbGpPWpGaD
Maraviroc—CYP3A4—Xenobiotics—CYP2D6—schizophrenia	0.00223	0.0034	CbGpPWpGaD
Maraviroc—CCR5—Signaling by GPCR—HTR6—schizophrenia	0.00221	0.00338	CbGpPWpGaD
Maraviroc—CCR5—GPCR ligand binding—HTR7—schizophrenia	0.00221	0.00337	CbGpPWpGaD
Maraviroc—CCR5—GPCR ligand binding—DRD2—schizophrenia	0.00221	0.00337	CbGpPWpGaD
Maraviroc—CYP3A4—Estrogen metabolism—CYP1A2—schizophrenia	0.00219	0.00335	CbGpPWpGaD
Maraviroc—CCR5—GPCR downstream signaling—CHRM1—schizophrenia	0.00215	0.00329	CbGpPWpGaD
Maraviroc—CYP3A4—Tamoxifen metabolism—CYP2D6—schizophrenia	0.00214	0.00327	CbGpPWpGaD
Maraviroc—CYP3A4—Aflatoxin activation and detoxification—CYP1A2—schizophrenia	0.0021	0.00321	CbGpPWpGaD
Maraviroc—CCR5—GPCR downstream signaling—IL3RA—schizophrenia	0.00209	0.0032	CbGpPWpGaD
Maraviroc—CCR5—Class A/1 (Rhodopsin-like receptors)—HTR2A—schizophrenia	0.00203	0.0031	CbGpPWpGaD
Maraviroc—CYP3A4—Xenobiotics—CYP1A2—schizophrenia	0.00201	0.00308	CbGpPWpGaD
Maraviroc—CCR5—GPCR downstream signaling—GRM5—schizophrenia	0.002	0.00306	CbGpPWpGaD
Maraviroc—CCR5—Signaling Pathways—DGKI—schizophrenia	0.00196	0.00299	CbGpPWpGaD
Maraviroc—CCR5—Signaling by GPCR—CHRM1—schizophrenia	0.00195	0.00298	CbGpPWpGaD
Maraviroc—CYP3A4—Tamoxifen metabolism—CYP1A2—schizophrenia	0.00194	0.00296	CbGpPWpGaD
Maraviroc—CCR5—Signaling by GPCR—IL3RA—schizophrenia	0.0019	0.00291	CbGpPWpGaD
Maraviroc—CYP3A4—Tryptophan metabolism—TPH1—schizophrenia	0.00189	0.00289	CbGpPWpGaD
Maraviroc—CYP3A4—Estrogen metabolism—COMT—schizophrenia	0.00184	0.00281	CbGpPWpGaD
Maraviroc—CCR5—GPCR downstream signaling—CCK—schizophrenia	0.00183	0.00279	CbGpPWpGaD
Maraviroc—CCR5—Signaling by GPCR—GRM5—schizophrenia	0.00181	0.00277	CbGpPWpGaD
Maraviroc—CYP3A4—Drug Induction of Bile Acid Pathway—ABCB1—schizophrenia	0.00181	0.00277	CbGpPWpGaD
Maraviroc—CCR5—Signaling Pathways—PPP1R1B—schizophrenia	0.00179	0.00274	CbGpPWpGaD
Maraviroc—CCR5—GPCR downstream signaling—PDE4B—schizophrenia	0.00178	0.00272	CbGpPWpGaD
Maraviroc—CCR5—TCR Signaling Pathway—AKT1—schizophrenia	0.00176	0.00269	CbGpPWpGaD
Maraviroc—CCR5—GPCR downstream signaling—CCKAR—schizophrenia	0.00175	0.00268	CbGpPWpGaD
Maraviroc—CYP3A4—Cytochrome P450 - arranged by substrate type—CYP26B1—schizophrenia	0.00171	0.00262	CbGpPWpGaD
Maraviroc—CCR5—GPCR downstream signaling—ADORA2A—schizophrenia	0.0017	0.0026	CbGpPWpGaD
Maraviroc—CYP3A4—Oxidation by Cytochrome P450—CYP26B1—schizophrenia	0.00169	0.00258	CbGpPWpGaD
Maraviroc—CYP3A4—Estrogen metabolism—GSTM1—schizophrenia	0.00168	0.00257	CbGpPWpGaD
Maraviroc—CCR5—Signaling Pathways—FZD3—schizophrenia	0.00166	0.00254	CbGpPWpGaD
Maraviroc—CCR5—Signaling by GPCR—CCK—schizophrenia	0.00166	0.00254	CbGpPWpGaD
Maraviroc—CCR5—Signaling by GPCR—PDE4B—schizophrenia	0.00162	0.00247	CbGpPWpGaD
Maraviroc—CCR5—Signaling by GPCR—CCKAR—schizophrenia	0.00159	0.00243	CbGpPWpGaD
Maraviroc—CCR5—GPCR downstream signaling—NPY—schizophrenia	0.00159	0.00243	CbGpPWpGaD
Maraviroc—CCR5—Disease—NRG3—schizophrenia	0.00157	0.00239	CbGpPWpGaD
Maraviroc—CCR5—Disease—TLE1—schizophrenia	0.00157	0.00239	CbGpPWpGaD
Maraviroc—CCR5—Signaling Pathways—GRM2—schizophrenia	0.00156	0.00239	CbGpPWpGaD
Maraviroc—CCR5—Signaling Pathways—FES—schizophrenia	0.00156	0.00239	CbGpPWpGaD
Maraviroc—CCR5—Signaling Pathways—TAAR6—schizophrenia	0.00156	0.00239	CbGpPWpGaD
Maraviroc—CCR5—Signaling Pathways—PPP3CC—schizophrenia	0.00156	0.00239	CbGpPWpGaD
Maraviroc—CCR5—GPCR ligand binding—HTR2A—schizophrenia	0.00155	0.00236	CbGpPWpGaD
Maraviroc—CCR5—Signaling by GPCR—ADORA2A—schizophrenia	0.00154	0.00236	CbGpPWpGaD
Maraviroc—CCR5—GPCR downstream signaling—HTR1B—schizophrenia	0.00153	0.00234	CbGpPWpGaD
Maraviroc—CCR5—GPCR downstream signaling—OXT—schizophrenia	0.00153	0.00234	CbGpPWpGaD
Maraviroc—CCR5—Disease—TLE3—schizophrenia	0.00148	0.00227	CbGpPWpGaD
Maraviroc—CCR5—GPCR downstream signaling—HTR1A—schizophrenia	0.00147	0.00225	CbGpPWpGaD
Maraviroc—CCR5—GPCR downstream signaling—NPS—schizophrenia	0.00145	0.00222	CbGpPWpGaD
Maraviroc—CCR5—Signaling Pathways—NGEF—schizophrenia	0.00145	0.00221	CbGpPWpGaD
Maraviroc—CCR5—Signaling by GPCR—NPY—schizophrenia	0.00144	0.0022	CbGpPWpGaD
Maraviroc—CCR5—GPCR downstream signaling—HTR2C—schizophrenia	0.00142	0.00218	CbGpPWpGaD
Maraviroc—CCR5—GPCR downstream signaling—DRD1—schizophrenia	0.00142	0.00218	CbGpPWpGaD
Maraviroc—CCR5—Signaling Pathways—NTS—schizophrenia	0.00141	0.00216	CbGpPWpGaD
Maraviroc—CCR5—Disease—GAPDH—schizophrenia	0.00141	0.00216	CbGpPWpGaD
Maraviroc—CCR5—Signaling by GPCR—OXT—schizophrenia	0.00139	0.00213	CbGpPWpGaD
Maraviroc—CCR5—Signaling by GPCR—HTR1B—schizophrenia	0.00139	0.00213	CbGpPWpGaD
Maraviroc—CYP3A4—Phase 1 - Functionalization of compounds—CYP26B1—schizophrenia	0.00139	0.00212	CbGpPWpGaD
Maraviroc—CCR5—GPCR downstream signaling—DRD3—schizophrenia	0.00138	0.00211	CbGpPWpGaD
Maraviroc—CCR5—Signaling by GPCR—HTR1A—schizophrenia	0.00134	0.00205	CbGpPWpGaD
Maraviroc—CCR5—GPCR downstream signaling—DRD4—schizophrenia	0.00134	0.00205	CbGpPWpGaD
Maraviroc—CCR5—Signaling Pathways—RTN4—schizophrenia	0.00133	0.00203	CbGpPWpGaD
Maraviroc—CCR5—Signaling Pathways—RGS4—schizophrenia	0.00133	0.00203	CbGpPWpGaD
Maraviroc—CCR5—Signaling Pathways—GRM3—schizophrenia	0.00133	0.00203	CbGpPWpGaD
Maraviroc—CCR5—Signaling by GPCR—NPS—schizophrenia	0.00132	0.00202	CbGpPWpGaD
Maraviroc—CYP3A4—Nuclear Receptors in Lipid Metabolism and Toxicity—CYP1A2—schizophrenia	0.00132	0.00201	CbGpPWpGaD
Maraviroc—CCR5—Signaling Pathways—HTR6—schizophrenia	0.00131	0.002	CbGpPWpGaD
Maraviroc—CCR5—Signaling by GPCR—DRD1—schizophrenia	0.00129	0.00198	CbGpPWpGaD
Maraviroc—CCR5—Signaling by GPCR—HTR2C—schizophrenia	0.00129	0.00198	CbGpPWpGaD
Maraviroc—CCR5—GPCR downstream signaling—CNR1—schizophrenia	0.00128	0.00195	CbGpPWpGaD
Maraviroc—CCR5—Signaling Pathways—MAG—schizophrenia	0.00126	0.00193	CbGpPWpGaD
Maraviroc—CCR5—Signaling by GPCR—DRD3—schizophrenia	0.00125	0.00191	CbGpPWpGaD
Maraviroc—CCR5—Disease—FGA—schizophrenia	0.00125	0.00191	CbGpPWpGaD
Maraviroc—CCR5—GPCR downstream signaling—DRD2—schizophrenia	0.00125	0.00191	CbGpPWpGaD
Maraviroc—CCR5—GPCR downstream signaling—HTR7—schizophrenia	0.00125	0.00191	CbGpPWpGaD
Maraviroc—CCR5—Signaling by GPCR—DRD4—schizophrenia	0.00122	0.00186	CbGpPWpGaD
Maraviroc—CCR5—Signaling by GPCR—CNR1—schizophrenia	0.00116	0.00177	CbGpPWpGaD
Maraviroc—CCR5—Signaling Pathways—CHRM1—schizophrenia	0.00115	0.00176	CbGpPWpGaD
Maraviroc—CCR5—Signaling by GPCR—HTR7—schizophrenia	0.00113	0.00173	CbGpPWpGaD
Maraviroc—CCR5—Signaling by GPCR—DRD2—schizophrenia	0.00113	0.00173	CbGpPWpGaD
Maraviroc—CCR5—Signaling Pathways—IL3RA—schizophrenia	0.00112	0.00172	CbGpPWpGaD
Maraviroc—CCR5—Signaling Pathways—TLE1—schizophrenia	0.0011	0.00168	CbGpPWpGaD
Maraviroc—CCR5—Signaling Pathways—NRG3—schizophrenia	0.0011	0.00168	CbGpPWpGaD
Maraviroc—CYP3A4—Constitutive Androstane Receptor Pathway—ABCB1—schizophrenia	0.00109	0.00167	CbGpPWpGaD
Maraviroc—CCR5—Disease—SNAP25—schizophrenia	0.00109	0.00167	CbGpPWpGaD
Maraviroc—CCR5—Signaling Pathways—GFAP—schizophrenia	0.00108	0.00166	CbGpPWpGaD
Maraviroc—CCR5—Signaling Pathways—GRM5—schizophrenia	0.00107	0.00164	CbGpPWpGaD
Maraviroc—CYP3A4—Metapathway biotransformation—NDST3—schizophrenia	0.00106	0.00162	CbGpPWpGaD
Maraviroc—CYP3A4—Nuclear Receptors in Lipid Metabolism and Toxicity—ABCB1—schizophrenia	0.00104	0.00159	CbGpPWpGaD
Maraviroc—CCR5—Signaling Pathways—TLE3—schizophrenia	0.00104	0.00159	CbGpPWpGaD
Maraviroc—CYP3A4—Tryptophan metabolism—CYP1A2—schizophrenia	0.00103	0.00158	CbGpPWpGaD
Maraviroc—CCR5—Signaling Pathways—CCK—schizophrenia	0.00098	0.0015	CbGpPWpGaD
Maraviroc—CCR5—Disease—HSPA1A—schizophrenia	0.000979	0.0015	CbGpPWpGaD
Maraviroc—CCR5—Disease—NOS1—schizophrenia	0.000972	0.00149	CbGpPWpGaD
Maraviroc—CCR5—Signaling Pathways—PDE4B—schizophrenia	0.000955	0.00146	CbGpPWpGaD
Maraviroc—CCR5—Signaling Pathways—CCKAR—schizophrenia	0.00094	0.00144	CbGpPWpGaD
Maraviroc—CYP3A4—Cytochrome P450 - arranged by substrate type—CYP2D6—schizophrenia	0.000924	0.00141	CbGpPWpGaD
Maraviroc—CYP3A4—Oxidation by Cytochrome P450—CYP2D6—schizophrenia	0.000912	0.0014	CbGpPWpGaD
Maraviroc—CCR5—Signaling Pathways—ADORA2A—schizophrenia	0.000911	0.00139	CbGpPWpGaD
Maraviroc—CCR5—Disease—PRL—schizophrenia	0.000902	0.00138	CbGpPWpGaD
Maraviroc—CCR5—Signaling by GPCR—PLA2G4A—schizophrenia	0.000896	0.00137	CbGpPWpGaD
Maraviroc—CCR5—Signaling Pathways—FGA—schizophrenia	0.000874	0.00134	CbGpPWpGaD
Maraviroc—CCR5—GPCR downstream signaling—HTR2A—schizophrenia	0.000873	0.00134	CbGpPWpGaD
Maraviroc—CCR5—Signaling Pathways—NOTCH4—schizophrenia	0.000851	0.0013	CbGpPWpGaD
Maraviroc—CCR5—Signaling Pathways—ATP2A2—schizophrenia	0.000851	0.0013	CbGpPWpGaD
Maraviroc—CCR5—Signaling Pathways—NPY—schizophrenia	0.000851	0.0013	CbGpPWpGaD
Maraviroc—CYP3A4—Cytochrome P450 - arranged by substrate type—CYP1A2—schizophrenia	0.000836	0.00128	CbGpPWpGaD
Maraviroc—CYP3A4—Oxidation by Cytochrome P450—CYP1A2—schizophrenia	0.000825	0.00126	CbGpPWpGaD
Maraviroc—CCR5—Signaling Pathways—HTR1B—schizophrenia	0.000822	0.00126	CbGpPWpGaD
Maraviroc—CCR5—Signaling Pathways—OXT—schizophrenia	0.000822	0.00126	CbGpPWpGaD
Maraviroc—CCR5—Disease—ERBB4—schizophrenia	0.000804	0.00123	CbGpPWpGaD
Maraviroc—CCR5—Signaling by GPCR—HTR2A—schizophrenia	0.000793	0.00121	CbGpPWpGaD
Maraviroc—CCR5—Signaling Pathways—HTR1A—schizophrenia	0.000791	0.00121	CbGpPWpGaD
Maraviroc—CCR5—Signaling Pathways—NPS—schizophrenia	0.000779	0.00119	CbGpPWpGaD
Maraviroc—CCR5—Signaling Pathways—DRD1—schizophrenia	0.000764	0.00117	CbGpPWpGaD
Maraviroc—CCR5—Signaling Pathways—HTR2C—schizophrenia	0.000764	0.00117	CbGpPWpGaD
Maraviroc—CYP3A4—Phase 1 - Functionalization of compounds—CYP2D6—schizophrenia	0.000749	0.00115	CbGpPWpGaD
Maraviroc—CCR5—Signaling Pathways—NTRK2—schizophrenia	0.000743	0.00114	CbGpPWpGaD
Maraviroc—CCR5—Disease—NRG1—schizophrenia	0.000742	0.00113	CbGpPWpGaD
Maraviroc—CCR5—Signaling Pathways—DRD3—schizophrenia	0.00074	0.00113	CbGpPWpGaD
Maraviroc—CYP3A4—Biological oxidations—CYP26B1—schizophrenia	0.000737	0.00113	CbGpPWpGaD
Maraviroc—CYP3A4—Metapathway biotransformation—CYP26B1—schizophrenia	0.000727	0.00111	CbGpPWpGaD
Maraviroc—CCR5—Signaling Pathways—DRD4—schizophrenia	0.000718	0.0011	CbGpPWpGaD
Maraviroc—CCR5—Disease—YWHAZ—schizophrenia	0.000711	0.00109	CbGpPWpGaD
Maraviroc—CCR5—Disease—ERBB3—schizophrenia	0.000695	0.00106	CbGpPWpGaD
Maraviroc—CCR5—Signaling Pathways—CNR1—schizophrenia	0.000686	0.00105	CbGpPWpGaD
Maraviroc—CYP3A4—Phase 1 - Functionalization of compounds—CYP1A2—schizophrenia	0.000678	0.00104	CbGpPWpGaD
Maraviroc—CCR5—Signaling Pathways—DRD2—schizophrenia	0.000669	0.00102	CbGpPWpGaD
Maraviroc—CCR5—Signaling Pathways—HTR7—schizophrenia	0.000669	0.00102	CbGpPWpGaD
Maraviroc—CCR5—Disease—MTHFR—schizophrenia	0.000668	0.00102	CbGpPWpGaD
Maraviroc—CYP3A4—Biological oxidations—GCLM—schizophrenia	0.000657	0.001	CbGpPWpGaD
Maraviroc—CCR5—Signaling Pathways—PRL—schizophrenia	0.000632	0.000966	CbGpPWpGaD
Maraviroc—CCR5—Disease—APOE—schizophrenia	0.000622	0.000951	CbGpPWpGaD
Maraviroc—CCR5—Disease—APOA1—schizophrenia	0.000615	0.00094	CbGpPWpGaD
Maraviroc—CCR5—Signaling Pathways—S100B—schizophrenia	0.000589	0.0009	CbGpPWpGaD
Maraviroc—CYP3A4—Phase 1 - Functionalization of compounds—MAOA—schizophrenia	0.000564	0.000862	CbGpPWpGaD
Maraviroc—CCR5—Signaling Pathways—ERBB4—schizophrenia	0.000563	0.000861	CbGpPWpGaD
Maraviroc—CCR5—Disease—GSK3B—schizophrenia	0.000539	0.000824	CbGpPWpGaD
Maraviroc—CCR5—Signaling Pathways—PLA2G4A—schizophrenia	0.000529	0.00081	CbGpPWpGaD
Maraviroc—CCR5—Signaling Pathways—NRG1—schizophrenia	0.00052	0.000795	CbGpPWpGaD
Maraviroc—CCR5—Signaling Pathways—MEF2C—schizophrenia	0.000515	0.000787	CbGpPWpGaD
Maraviroc—CCR5—Signaling Pathways—YWHAZ—schizophrenia	0.000498	0.000761	CbGpPWpGaD
Maraviroc—CCR5—Signaling Pathways—ERBB3—schizophrenia	0.000487	0.000744	CbGpPWpGaD
Maraviroc—CCR5—Signaling Pathways—HTR2A—schizophrenia	0.000469	0.000716	CbGpPWpGaD
Maraviroc—CCR5—Signaling Pathways—APOE—schizophrenia	0.000436	0.000666	CbGpPWpGaD
Maraviroc—CCR5—Signaling Pathways—APOA1—schizophrenia	0.000431	0.000658	CbGpPWpGaD
Maraviroc—CCR5—Signaling Pathways—ESR1—schizophrenia	0.000416	0.000636	CbGpPWpGaD
Maraviroc—CYP3A4—Biological oxidations—CYP2D6—schizophrenia	0.000398	0.000609	CbGpPWpGaD
Maraviroc—CYP3A4—Metapathway biotransformation—CYP2D6—schizophrenia	0.000393	0.0006	CbGpPWpGaD
Maraviroc—CCR5—Signaling Pathways—GSK3B—schizophrenia	0.000377	0.000577	CbGpPWpGaD
Maraviroc—CYP3A4—Biological oxidations—CYP1A2—schizophrenia	0.00036	0.000551	CbGpPWpGaD
Maraviroc—CYP3A4—Metapathway biotransformation—CYP1A2—schizophrenia	0.000355	0.000543	CbGpPWpGaD
Maraviroc—CCR5—Disease—EP300—schizophrenia	0.000354	0.000542	CbGpPWpGaD
Maraviroc—CYP3A4—Biological oxidations—COMT—schizophrenia	0.000302	0.000461	CbGpPWpGaD
Maraviroc—CYP3A4—Biological oxidations—GSTP1—schizophrenia	0.0003	0.000459	CbGpPWpGaD
Maraviroc—CYP3A4—Biological oxidations—MAOA—schizophrenia	0.0003	0.000458	CbGpPWpGaD
Maraviroc—CYP3A4—Metapathway biotransformation—COMT—schizophrenia	0.000298	0.000455	CbGpPWpGaD
Maraviroc—CYP3A4—Metapathway biotransformation—GSTP1—schizophrenia	0.000296	0.000453	CbGpPWpGaD
Maraviroc—CCR5—GPCR downstream signaling—AKT1—schizophrenia	0.00028	0.000428	CbGpPWpGaD
Maraviroc—CYP3A4—Biological oxidations—GSTM1—schizophrenia	0.000276	0.000422	CbGpPWpGaD
Maraviroc—CYP3A4—Metapathway biotransformation—GSTM1—schizophrenia	0.000272	0.000416	CbGpPWpGaD
Maraviroc—CYP3A4—Metabolism—PRODH—schizophrenia	0.000258	0.000395	CbGpPWpGaD
Maraviroc—CCR5—Signaling by GPCR—AKT1—schizophrenia	0.000254	0.000388	CbGpPWpGaD
Maraviroc—CCR5—Signaling Pathways—EP300—schizophrenia	0.000248	0.00038	CbGpPWpGaD
Maraviroc—CCR5—Disease—AKT1—schizophrenia	0.000214	0.000328	CbGpPWpGaD
Maraviroc—CYP3A4—Metabolism—MPC2—schizophrenia	0.00021	0.000322	CbGpPWpGaD
Maraviroc—CYP3A4—Metabolism—PLCH2—schizophrenia	0.000196	0.000299	CbGpPWpGaD
Maraviroc—CYP3A4—Metabolism—NDST3—schizophrenia	0.000184	0.000281	CbGpPWpGaD
Maraviroc—CCR5—Signaling Pathways—TP53—schizophrenia	0.000178	0.000272	CbGpPWpGaD
Maraviroc—CYP3A4—Metabolism—SLC27A5—schizophrenia	0.000174	0.000267	CbGpPWpGaD
Maraviroc—CYP3A4—Metabolism—ACSL6—schizophrenia	0.000174	0.000267	CbGpPWpGaD
Maraviroc—CYP3A4—Metabolism—DAO—schizophrenia	0.000166	0.000254	CbGpPWpGaD
Maraviroc—CYP3A4—Metabolism—PNP—schizophrenia	0.000159	0.000244	CbGpPWpGaD
Maraviroc—CCR5—Signaling Pathways—AKT1—schizophrenia	0.00015	0.000229	CbGpPWpGaD
Maraviroc—CYP3A4—Metabolism—NDUFV2—schizophrenia	0.000148	0.000227	CbGpPWpGaD
Maraviroc—CYP3A4—Metabolism—PIP4K2A—schizophrenia	0.000139	0.000213	CbGpPWpGaD
Maraviroc—CYP3A4—Metabolism—CYP26B1—schizophrenia	0.000126	0.000193	CbGpPWpGaD
Maraviroc—CYP3A4—Metabolism—GCLM—schizophrenia	0.000112	0.000172	CbGpPWpGaD
Maraviroc—CYP3A4—Metabolism—TPH1—schizophrenia	0.000112	0.000172	CbGpPWpGaD
Maraviroc—CYP3A4—Metabolism—PRKD1—schizophrenia	0.000106	0.000162	CbGpPWpGaD
Maraviroc—CYP3A4—Metabolism—GAPDH—schizophrenia	8.82e-05	0.000135	CbGpPWpGaD
Maraviroc—CYP3A4—Metabolism—CLOCK—schizophrenia	8.74e-05	0.000134	CbGpPWpGaD
Maraviroc—CYP3A4—Metabolism—TPH2—schizophrenia	8.52e-05	0.00013	CbGpPWpGaD
Maraviroc—CYP3A4—Metabolism—CACNB2—schizophrenia	8.52e-05	0.00013	CbGpPWpGaD
Maraviroc—CYP3A4—Metabolism—DPYD—schizophrenia	8.38e-05	0.000128	CbGpPWpGaD
Maraviroc—CYP3A4—Metabolism—CACNA1C—schizophrenia	7.79e-05	0.000119	CbGpPWpGaD
Maraviroc—CYP3A4—Metabolism—PIK3C2A—schizophrenia	7.59e-05	0.000116	CbGpPWpGaD
Maraviroc—CYP3A4—Metabolism—CYP2D6—schizophrenia	6.81e-05	0.000104	CbGpPWpGaD
Maraviroc—CYP3A4—Metabolism—SNAP25—schizophrenia	6.81e-05	0.000104	CbGpPWpGaD
Maraviroc—CYP3A4—Metabolism—CYP1A2—schizophrenia	6.16e-05	9.41e-05	CbGpPWpGaD
Maraviroc—CYP3A4—Metabolism—TH—schizophrenia	6.07e-05	9.28e-05	CbGpPWpGaD
Maraviroc—CYP3A4—Metabolism—COMT—schizophrenia	5.16e-05	7.89e-05	CbGpPWpGaD
Maraviroc—CYP3A4—Metabolism—GSTP1—schizophrenia	5.13e-05	7.85e-05	CbGpPWpGaD
Maraviroc—CYP3A4—Metabolism—MAOA—schizophrenia	5.12e-05	7.83e-05	CbGpPWpGaD
Maraviroc—CYP3A4—Metabolism—ABCB1—schizophrenia	4.86e-05	7.43e-05	CbGpPWpGaD
Maraviroc—CYP3A4—Metabolism—GSTM1—schizophrenia	4.72e-05	7.22e-05	CbGpPWpGaD
Maraviroc—CYP3A4—Metabolism—PLA2G4A—schizophrenia	4.72e-05	7.22e-05	CbGpPWpGaD
Maraviroc—CYP3A4—Metabolism—MTHFR—schizophrenia	4.17e-05	6.38e-05	CbGpPWpGaD
Maraviroc—CYP3A4—Metabolism—APOE—schizophrenia	3.88e-05	5.94e-05	CbGpPWpGaD
Maraviroc—CYP3A4—Metabolism—APOA1—schizophrenia	3.84e-05	5.87e-05	CbGpPWpGaD
Maraviroc—CYP3A4—Metabolism—EP300—schizophrenia	2.21e-05	3.38e-05	CbGpPWpGaD
Maraviroc—CYP3A4—Metabolism—AKT1—schizophrenia	1.34e-05	2.04e-05	CbGpPWpGaD
